Curious about Low Dose Naltrexone (LDN) for rheumatoid arthritis? Learn benefits, limits, dosing, safety, costs, and how to start responsibly.
Low Dose Naltrexone (LDN) may help some people with rheumatoid arthritis feel less pain and function better, but it’s an adjunct, not a replacement for standard rheumatoid arthritis therapy [1][2][3].
Rheumatoid Arthritis is inflammatory, painful, and relentless. If a low-cost, generally well-tolerated add-on can improve symptoms for some, it’s worth knowing the facts before you try it [1][7][8].
Evidence is promising yet limited. Low Dose Naltrexone (LDN) is used off-label, dosing isn’t standardized, and it cannot be combined with opioid medications [2][8].
Low Dose Naltrexone uses a tiny fraction (typically 1.5–4.5 mg daily) of the standard 50 mg naltrexone tablet dose [2][3][4]. In low doses, it’s thought to briefly block opioid receptors, prompting a rebound effect that may dampen inflammation and modulate immune activity [5][9]. LDN is not FDA-approved for RA and isn’t a first-line therapy, but interest is growing as a complementary option [1][2][3].
People living with autoimmune or chronic pain conditions sometimes explore LDN for:
It’s used off-label in conditions like RA, fibromyalgia, Crohn’s disease, and chronic pain disorders [2][3]. Expectations should be realistic: LDN is an add-on, not a cure.
For RA:
Data are limited but suggest potential benefits for some persistent users, including reduced pain and, in some reports, decreased need for other medications [1][7]. The signal is encouraging, yet larger randomized trials are still needed to confirm who benefits and by how much [1][8].
Immune support and mood:
Mechanistic theories support immune modulation via endogenous opioid upregulation [9][10]. Some early work hints at mood and quality-of-life improvements [7][10], but the most consistent evidence centers on pain and inflammation rather than mood [1][7].
Safety profile:
At 1.5–4.5 mg daily, LDN is generally well tolerated [1][2][3][4][5][6]. The most common mild effects are sleep changes or vivid dreams, especially early on [4][5]. Serious adverse events are rare [2][3].
Important: LDN should never be used with opioid therapy, as it can precipitate withdrawal and block analgesia [8].
Think of LDN as a potential anti-inflammatory adjunct for chronic pain within a comprehensive plan [5][7]. It does not replace DMARDs or biologics that slow RA progression and protect joints [1][7]. Keep your rheumatologist in the loop so your regimen stays balanced and evidence-based [1].
There are no official US guidelines for LDN dosing in RA. Use is off-label and individualized [1].
There’s no commercial low-dose naltrexone product. Standard tablets are 50 mg and can’t be split accurately to reach 1.5–4.5 mg [4][5]. A licensed compounding pharmacy prepares precise low-dose capsules or liquid.
LDN is a promising, investigational add-on for rheumatoid arthritis [1][2][3]. Some patients report improved pain and function, and the safety profile at low doses is generally favorable [4][5][6]. Still, higher-quality trials are needed [1][8]. If you’re curious, explore it with a clinician who can tailor dosing, monitor progress, and safeguard your core RA treatment.
Health concerns, no matter how minor they may seem, can severely impact your overall well-being and quality of life. If you're experiencing symptoms or have concerns about a specific health condition, remember that timely and expert advice is key. Navigating healthcare can be challenging, but finding the right primary care physician shouldn't be. Whether you're seeking medical advice, a prescription or care, immediate access to expert primary care is just a button away. Don’t leave your health to chance - consult a Well Revolution primary care provider today for peace of mind and professional care.
Concerned, need advice, a prescription, refill or referral?
Text a doctor now
